We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.5M
AUM Growth
-$140M
Cap. Flow
-$147M
Cap. Flow %
-161.07%
Top 10 Hldgs %
32.18%
Holding
147
New
3
Increased
5
Reduced
92
Closed
38

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$327K
2
COL
Rockwell Collins
COL
+$213K
3
CBRL icon
Cracker Barrel
CBRL
+$19.9K
4
SRCL
Stericycle Inc
SRCL
+$18.3K
5
FRC
First Republic Bank
FRC
+$11.6K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.51M
2
CNI icon
Canadian National Railway
CNI
+$5.43M
3
NVS icon
Novartis
NVS
+$5.24M
4
MA icon
Mastercard
MA
+$5.23M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 24.99%
2 Healthcare 21.06%
3 Industrials 19.34%
4 Energy 10.11%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
26
Home Depot
HD
$329B
$1.3M 1.42%
12,375
-17,073
-58% -$1.66M
SLB icon
27
SLB Ltd
SLB
$85.1B
$1.29M 1.41%
15,135
-34,120
-69% -$3.14M
ROK icon
28
Rockwell Automation
ROK
$47.8B
$1.28M 1.4%
11,515
-27,764
-71% -$3.05M
IPGP icon
29
IPG Photonics
IPGP
$3.26B
$1.24M 1.35%
16,490
-38,925
-70% -$2.77M
GE icon
30
GE Aerospace
GE
$355B
$1.14M 1.25%
9,445
-1,801
-16% -$221K
CSCO icon
31
Cisco
CSCO
$433B
$1.1M 1.21%
39,700
-58,703
-60% -$1.52M
HON icon
32
Honeywell
HON
$68.9B
$1.1M 1.2%
12,242
-5
-0% -$430
DD
33
DELISTED
Du Pont De Nemours E I
DD
$1.08M 1.18%
15,350
-227
-1% -$15.2K
PRGO icon
34
Perrigo
PRGO
$2.01B
$1.07M 1.17%
6,385
-19,408
-75% -$3.04M
MSFT icon
35
Microsoft
MSFT
$3.81T
$971K 1.06%
20,895
-41,521
-67% -$1.95M
TGT icon
36
Target
TGT
$74.1B
$959K 1.05%
12,630
-28,970
-70% -$1.96M
ABBV icon
37
AbbVie
ABBV
$451B
$865K 0.95%
13,215
-700
-5% -$44.1K
IBM icon
38
IBM
IBM
$222B
$725K 0.79%
4,725
-4,590
-49% -$730K
HP icon
39
Helmerich & Payne
HP
$4.25B
$704K 0.77%
10,445
-29,450
-74% -$2.29M
MRK icon
40
Merck
MRK
$366B
$687K 0.75%
12,686
-7,965
-39% -$444K
NSC icon
41
Norfolk Southern
NSC
$78.3B
$658K 0.72%
6,000
– –
ABB
42
DELISTED
ABB Ltd
ABB
$548K 0.6%
25,900
-64,775
-71% -$1.4M
ILMN icon
43
Illumina
ILMN
$32.6B
$537K 0.59%
2,991
-11,920
-80% -$2.1M
BMY icon
44
Bristol-Myers Squibb
BMY
$136B
$536K 0.59%
9,082
-765
-8% -$43.1K
NVO
45
Novo Nordisk
NVO
$202B
$466K 0.51%
22,000
– –
GPC icon
46
Genuine Parts
GPC
$19B
$462K 0.51%
4,332
-60
-1% -$5.88K
UNFI icon
47
United Natural Foods
UNFI
$2.77B
$460K 0.5%
5,950
-8,607
-59% -$608K
RPM icon
48
RPM International
RPM
$13.6B
$447K 0.49%
8,814
-60
-0.7% -$2.79K
XLNX
49
DELISTED
Xilinx Inc
XLNX
$415K 0.45%
9,610
-27,090
-74% -$1.17M
COP icon
50
ConocoPhillips
COP
$157B
$397K 0.43%
5,750
-5
-0.1% -$349
1
2
3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q4 2014 Portfolio in Review

As of Q4 2014, Michael B. Elefante held 147 positions worth $91.5M, down 61% from $232M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante withdrew a net $147M in Q4 2014, closing 38 positions and reducing 92 holdings. Its most notable exit was Labcorp, an estimated $1.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Michael B. Elefante opened a new position in CDK Global, Inc. worth $375K.

  • Michael B. Elefante's largest Q4 2014 buy was CDK Global, Inc.: 9,235 shares worth $375K.
  • Michael B. Elefante added most to Stericycle Inc in Q4 2014, an estimated $18.3K increase.
  • Michael B. Elefante's biggest Q4 2014 reduction was CVS Health, cutting an estimated $6.51M.
  • Michael B. Elefante fully exited Labcorp in Q4 2014, selling an estimated $1.76M.
  • Michael B. Elefante's ten largest holdings make up 32% of its $91.5M portfolio in Q4 2014.
  • Michael B. Elefante opened 3 new positions and closed 38 in Q4 2014.
  • Michael B. Elefante's portfolio value fell 61% quarter-over-quarter to $91.5M.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.